Cytodyn Inc (CYDY)

[kgromax]

Cytodyn is a Pump & Dump scam. Putting lipstick on the pig won't work.

A prediction of bankruptcy in six weeks is baseless. Perhaps you can share objective evidence to support that claim.

The company 10K posted on the SEC database. You can freely access it through EDGAR or Cytodyn's website. Look for the balance sheet. Then look for the cashflow statements. Then take into account the lost lawsuits, etc...
DEBUNKED

You hold that my argument is fact less, but I referenced real clinical trials while you have dismissed CD12 trial results with putative statistical analysis.

I remember our discussions and our disagreement back then. Yet, magically, I predicted correctly that the trial's endpoint would not be statistically significant. And your prediction (that the endpoints would be stat sig) got proven wrong. My prediction was also fact-based: dozens of detailed Twitter posts (some cross referenced on this board) and comparative analysis across >100 comparable studies, worldwide as well as in Asia. All this anaysis is still accessible on Twitter (look for @kgromax posts).
DEBUNKED

Perhaps you should share your observations with the 35 hospitals in Brazil who, having seen the CD12 results, are wasting their time and putting their patients at risk with leronlimab trials.

Yep exactly like the CD10 and CD12 hospitals. That's a pretty classic thing: enrollment does exactly that, in every study. First you enroll, which starts with finding hospials. If that were a proof that something is working there would be no trial. We would just ask hospitals "Does Salinimab works?", collect the votes and bam approve....
DEBUNKED

The other part of the torsion spring analogy that I simply love is that the nature of the threat is not apparent amd easily overlooked.

Only investment beginners would believe that. This stock is a classical case of pump & dump, a very common type of fraud. It follows all the patterns. The "threat" is just another pump and another squeeze. Of course, experienced short-sellers account for that and size their position to (1) be able to be very patient (2) capture the next squeeze. I read that someone found Cytodyn to be an "extreme" case of short-sold stock. It made me laugh. CYDY spikes and crashes are nothing compared to TLRY, AMC, GME, and spikes of the past.
DEBUNKED

Far, far, far too many are involved with Cytodyn, holders of both long and short positions without an inking of the underlying science.

I have 2 MS, including one in Statistics, plus a good background in many fields from Quantum physics to Molecular biology, Information Theory, ... The stats published by Cytodyn are all biased, magically incomplete on what matters, and wrong on p-values and their interpretation. Sorry, that's my specialty and it's very obvious to anyone that is specialized there. Like, obvious after a 30 seconds read. So I agree with you: many holders lack a basic understanding of science.

Let’s revisit this conversation (six weeks is too early) once we see CD16 and 17 results, should you have sufficient patience.

Wait wait you said already that to me for CD12: that you would wait for the trial outcome to recognize if I was correct or not. You never did. You can't use that rationale twice. First, you have to execute the previous promise. Do you recognize that you failed on CD12?